Pasi Kemppainen

Pasi is Principal Advisor for pharma digitalization strategic initiatives and transformation implementations at Epista Life Science, leader in life science compliance consulting and advisory. His expertise and customer assignments cover pharma medicine serialization and traceability, manufacturing IT, and new digitalization technologies such as IoT and distributed ledger technologies. Prior to Epista, Pasi worked as Senior Consultant and Advisor at NNE, Novo Nordisk engineering and consulting company, in medicine serialization and traceability, and manufacturing automation IT projects. Pasi served as Chief Executive Officer at Original1 GmbH (a joint venture of SAP, Nokia and Giesecke&Devrient - leaders in enterprise IT, mobile and security) servicing a cloud and mobile platform for product serialization, traceability and consumer authentication services in Europe and China.. Before Original1, Pasi headed Nokia Authentication Solution business in Nokia China empowering consumers and businesses to authenticate product originality and counterfeits using their mobile phones. The products covered consumer products, drugs and ID cards and ultimately the solution was selected as the best anti-counterfeit solution in China by China RFID Journal and China Anti-counterfeit Association.